CAS: 14573-23-0; 2,6-Dichlorophenethylamine

该化合物其结构特征为该化合物其结构特征为:芬乙胺脊柱,在苯环的2和6个位置上有两个氯替代物;该化合物一般无色可粉黄黄色液体或固态,视其纯度和形态而定;以其在制药和有机合成中作为中间体的潜在用途而著称;氯原子的存在可增强其反应性并影响其生物活动;2.6-二氯苯乙胺可能显示出有机溶剂中度溶解性和水中限溶性等特性,许多氯化有机化合物都普遍存在这种特性;安全数据表明,如果吸入,摄取或通过皮肤吸收,可能会对健康造成危害,因此应谨慎处理该化合物.与许多阿明物质一样,氯原子可以参与各种化学反应,包括碱和相互交织,使其成为合成化学的多用途建筑块.

结构式图片

相似化合物

78433-88-2 52516-13-9 13078-80-3

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号52287-52-2 2,6-dichloronit... | CAS号3215-64-3 2,6-二氯苯乙腈 | CAS号83-38-5 2,6-二氯苯甲醛 | CAS号79988-70-8 5,5-methylenebi... | CAS号79988-69-5 Pyrimido[4,5-d]...

合成工艺路线路线简述

    反-2,6-二氯-β-硝基苯乙烯置于lithium Aluminium Tetrahydride体系中,用 乙醚 用作溶剂,化学反应 3.0H,以58%的收率获得2,4-二氯苯酚呋喃
    参考文献:Gasteiger; Holzgrabe; Kostenis,Pharmazie,1995,Vol. 50,# 2,P. 99-105
    标题:Gasteiger; Holzgrabe; Kostenis,Pharmazie,1995,Vol. 50,# 2,P. 99-105

    海关参考信息

    专利信息


    专利号:US-5977301-A
    优先权日:1992-09-24
    标题 :Synthesis of N-substituted oligomers
    发明人:ZUCKERMAN RONALD N; KERR JANICE M; KENT STEPHEN B H; MOOS WALTER H; SIMON REYNA J; GOFF DANE A
    权利人:CHIRON CORP
    摘要:A solid-phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycines) (referred to herein as poly NSGs) is used to obtain oligomers, such as poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability.

    专利号:EP-0671928-B1
    优先权日:1992-09-24
    标题 :Synthesis of n-substituted oligomers
    发明人:ZUCKERMANN RONALD N; KERR JANICE M; KENT STEPHEN BRIAN HENRY; MOOS WALTER H; SIMON REYNA J; GOFF DANE A
    权利人:CHIRON CORP
    摘要:Poly N-substituted Glycines (poly NSGs), wherein the substituents bear purine or pyrimidine bases (R<9>) every second glycine: In addition, a solid phase method for the synthesis of N-substituted oligomers of more general structures is disclosed.The poly NSGs obtainable by this method can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a resin-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using the automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability.

    专利号:US-5877278-A
    优先权日:1992-09-24
    标题:Synthesis of N-substituted oligomers
    发明人:ZUCKERMANN RONALD N; GOFF DANE A; NG SIMON; SPEAR KERRY; SCOTT BARBARA O; SIGMUND AARON C; GOLDSMITH RICHARD A; MARLOWE CHARLES K; PEI YAZHONG; RICHTER LUTZ; SIMON REYNA
    权利人:CHIRON CORP
    摘要:A solid-phase method for the synthesis of N-substituted oligomers, such as poly (N-substituted glycines) (referred to herein as poly NSGs) is used to obtain oligomers, such as poly NSGs of potential therapeutic interest which poly NSGs can have a wide variety of side-chain substituents. Each N-substituted glycine monomer is assembled from two 'sub-monomers' directly on the solid support. Each cycle of monomer addition consists of two steps: (1) acylation of a secondary amine bound to the support with an acylating agent comprising a leaving group capable of nucleophilic displacement by -NH2, such as a haloacetic acid, and (2) introduction of the side-chain by nucleophilic displacement of the leaving group, such as halogen (as a solid support-bound alpha -haloacetamide) with a sufficient amount of a second sub-monomer comprising an -NH2 group, such as a primary amine, alkoxyamine, semicarbazide, acyl hydrazide, carbazate or the like. Repetition of the two step cycle of acylation and displacement gives the desired oligomers. The efficient synthesis of a wide variety of oligomeric NSGs using automated synthesis technology of the present method makes these oligomers attractive candidates for the generation and rapid screening of diverse peptidomimetic libraries. The oligomers of the invention, such as N-substituted glycines (i.e. poly NSGs) disclosed here provide a new class of peptide-like compounds not found in nature, but which are synthetically accessible and have been shown to possess significant biological activity and proteolytic stability. Combinatorial libraries of cyclic compounds are disclosed wherein the cyclic compounds are comprised of at least one ring structure derived from cyclization of a peptoid backbone. The diversity of product compounds is generated by the sequential addition of substituted submonomers. The combinatorial library includes 10 or more, preferably 100 or more, and more preferably 1,000 or more distinct and different compounds. The library includes each of the product compounds in retrievable and analyzable amounts and preferably includes at least one biologically active compound. Methods of synthesizing the combinatorial libraries and assay devices produced using the libraries are disclosed as is methodology for screening for and obtaining biologically active cyclic organic compounds.

    专利号:EP-0671928-A4
    优先权日:1992-09-24
    标 题 :SYNTHESIS OF N-SUBSTITUTED OLIGOMERS.

    专利号:EP-0789577-A1
    优先权日:1995-06-07
    标 题:Synthesis of n-substituted oligomers

    专利号:JP-3943593-B2
    优先权日:1995-06-07
    标题:Synthesis of N-substituted oligomers
    连云港淳达化工科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chundachem.com
    电话: 0518-88581638 13706140298👤
    📞连云港淳达化工科技有限公司 ⚠️参考联系方式

    销售电话:0518-88581638 13706140298
    邮箱:fxz@chundachem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/j.bmc.2008.06.009
    摘要:Lewin AH, Navarro HA, Wayne Mascarella S. Structure–activity correlations for β-phenethylamines at human trace amine receptor 1. Bioorganic & Medicinal Chemistry. 2008 Aug;16(15):7415–23. doi: 10.1016/j.bmc.2008.06.009.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知